{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:40:55Z","timestamp":1793187655127,"version":"4.5.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Comput Assist Tomogr"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The objective of this study was to investigate the correlation between dual-energy computed tomography (DECT)\u2013based iodine quantitation and fluorine-18 fluorodeoxyglucose (<jats:sup>18<\/jats:sup>F-FDG) positron emission tomography (PET)\/computed tomography (CT) imaging for response evaluation of lung cancers to treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this prospective study, a total of 32 pairs of DECT and <jats:sup>18<\/jats:sup>F-FDG PET\/CT imaging acquired consecutively from 13 patients with primary or metastatic lung cancers receiving either radiotherapy alone or chemoradiotherapy were analyzed. Imaging examinations were performed before, immediately, and no later than 6 months after treatment for response evaluation. Iodine-related parameters including the total iodine uptake (TIU) and vital volume (VIV) from DECT and metabolic metrics such as the standardized uptake value normalized to lean body mass (SULpeak), metabolic tumor volume (MTV), and the total lesion glycolysis (TLG) from <jats:sup>18<\/jats:sup>F-FDG-PET\/CT were generated and measured by semiautomatic approaches. Dual-energy CT and PET\/CT metrics were calculated and followed up with comparison with response evaluation criteria in solid tumors (RECIST).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Analysis of pretreatment imaging data revealed a strong correlation between DECT metrics (RECIST, TIU, and VIV) and <jats:sup>18<\/jats:sup>F-FDG PET\/CT metrics (MTV, TLG) with coefficients of <jats:italic toggle=\"yes\">R<\/jats:italic> ranging from 0.86 to 0.90 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01). With the delivery of treatment, all measured DECT and PET\/CT metrics significantly decreased whereas the descending amplitude in RECIST was significantly smaller than that of the remaining parameters (<jats:italic toggle=\"yes\">P &lt;<\/jats:italic> 0.05). During follow-up examinations, both metrics followed a similar changing pattern. Overall, strong consistency was found between RECIST, TIU, VIV and SULpeak, MTV, TLG (<jats:italic toggle=\"yes\">R<\/jats:italic> covers 0.78\u20130.96, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Semiautomatic iodine-related quantitation in DECT correlated well with metabolism-based measurements in <jats:sup>18<\/jats:sup>F-FDG PET\/CT, suggesting that DECT-based iodine quantitation might be a feasible substitute for assessment of lung cancer response to chemoradiotherapy\/radiotherapy with comparison with <jats:sup>18<\/jats:sup>F-FDG PET\/CT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rct.0000000000000734","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T15:19:38Z","timestamp":1522768778000},"page":"614-622","source":"Crossref","is-referenced-by-count":20,"title":["Dual-Energy Computed Tomography\u2013Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy\/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography\u2013Based Positron Emission Tomography\/Computed Tomography Response Evaluation Criterion in Solid Tumors"],"prefix":"10.1097","volume":"42","author":[{"given":"Yanping","family":"Ren","sequence":"first","affiliation":[{"name":"Radiation Oncology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Jiao","sequence":"additional","affiliation":[{"name":"Radiation Oncology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Ge","sequence":"additional","affiliation":[{"name":"Radiation Oncology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Radiation Oncology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Hua","sequence":"additional","affiliation":[{"name":"Radiology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[{"name":"Radiology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihao","family":"Zhai","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, Fudan University Huadong Hospital;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Tang","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, Fudan University Huadong Hospital;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, Fudan University Huadong Hospital;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Fang","sequence":"additional","affiliation":[{"name":"Siemens Healthineers; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangpeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20230927","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2967\/jnumed.111.102566","article-title":"Response assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non-small cell lung cancer","volume":"53","year":"2012","journal-title":"J Nucl Med"},{"key":"bib2-20230927","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.diii.2016.09.001","article-title":"Evaluation of lung tumor response to therapy: current and emerging techniques","volume":"97","year":"2016","journal-title":"Diagn Interv Imaging"},{"issue":"suppl 1","key":"bib3-20230927","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","year":"2009","journal-title":"J Nucl Med"},{"key":"bib4-20230927","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2214\/AJR.16.16532","article-title":"The value of FDG PET\/CT in treatment response assessment, follow-up, and surveillance of lung cancer","volume":"208","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"bib5-20230927","first-page":"181","article-title":"Dual-energy CT revisited with multidetector CT: review of principles and clinical applications","volume":"17","year":"2011","journal-title":"Diagn Interv Radiol"},{"key":"bib6-20230927","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00330-014-3223-9","article-title":"Dual-phase dual-energy CT in patients with lung cancer: assessment of the additional value of iodine quantification in lymph node therapy response","volume":"24","year":"2014","journal-title":"Eur Radiol"},{"key":"bib7-20230927","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00330-011-2230-3","article-title":"Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT?","volume":"22","year":"2012","journal-title":"Eur Radiol"},{"key":"bib8-20230927","doi-asserted-by":"crossref","first-page":"20150224","DOI":"10.1259\/bjr.20150224","article-title":"Evaluation of lung cancer by enhanced dual-energy CT: association between three-dimensional iodine concentration and tumour differentiation","volume":"88","year":"2015","journal-title":"Br J Radiol"},{"key":"bib10-20230927","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00259-009-1297-4","article-title":"FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: version 1.0","volume":"37","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib11-20230927","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s00259-014-2844-1","article-title":"What parameters from 18F-FDG PET\/CT are useful in evaluation of adrenal lesions?","volume":"41","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib12-20230927","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1148\/radiol.13130652","article-title":"Volume-based parameters measured by using FDG PET\/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value","volume":"270","year":"2014","journal-title":"Radiology"},{"key":"bib13-20230927","first-page":"1342","article-title":"Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer","volume":"46","year":"2005","journal-title":"J Nucl Med"},{"key":"bib14-20230927","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jaad.2012.02.010","article-title":"Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0","volume":"67","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"bib15-20230927","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1148\/radiol.14141398","article-title":"Relationship between overall survival of patients with non-small cell lung cancer and whole-body metabolic tumor burden seen on postsurgical fluorodeoxyglucose PET Images","volume":"275","year":"2015","journal-title":"Radiology"},{"key":"bib16-20230927","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4274\/mirt.36349","article-title":"Morphologic and metabolic comparison of treatment responsiveness with 18fludeoxyglucose-positron emission tomography\/computed tomography according to lung cancer type","volume":"25","year":"2016","journal-title":"Mol Imaging Radionucl Ther"},{"key":"bib17-20230927","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1200\/JCO.2015.64.0391","article-title":"Evaluation of immune-related response criteria and RECIST v1.1 in patients with advanced melanoma treated with pembrolizumab","volume":"34","year":"2016","journal-title":"J Clin Oncol"},{"key":"bib18-20230927","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","year":"1981","journal-title":"Cancer"},{"key":"bib19-20230927","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"bib20-20230927","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","year":"2009","journal-title":"Eur J Cancer"},{"key":"bib21-20230927","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0959-8049(99)00229-4","article-title":"Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group","volume":"35","year":"1999","journal-title":"Eur J Cancer"},{"key":"bib22-20230927","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/RLI.0b013e31820e1486","article-title":"Quantification of liver fat in the presence of iron and iodine: an ex-vivo dual-energy CT study","volume":"46","year":"2011","journal-title":"Invest Radiol"},{"key":"bib23-20230927","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/RLI.0b013e318229fef3","article-title":"Dual-energy computed tomography imaging of thyroid nodule specimens: comparison with pathologic findings","volume":"47","year":"2012","journal-title":"Invest Radiol"},{"key":"bib24-20230927","doi-asserted-by":"crossref","first-page":"20150573","DOI":"10.1259\/bjr.20150573","article-title":"Functional imaging of interstitial brachytherapy in pancreatic carcinoma xenografts using spectral CT: how does iodine concentration correlate with standardized uptake value of (18)FDG-PET-CT?","volume":"89","year":"2016","journal-title":"Br J Radiol"},{"key":"bib25-20230927","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.ejrad.2016.05.016","article-title":"Dual-energy dynamic CT of lung adenocarcinoma: correlation of iodine uptake with tumor gene expression","volume":"85","year":"2016","journal-title":"Eur J Radiol"},{"key":"bib26-20230927","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","year":"2011","journal-title":"Cell"},{"key":"bib27-20230927","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nrc909","article-title":"VEGF and the quest for tumour angiogenesis factors","volume":"2","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"bib28-20230927","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.crad.2015.12.013","article-title":"Correlation between vascular endothelial growth factor and quantitative dual-energy spectral CT in non-small-cell lung cancer","volume":"71","year":"2016","journal-title":"Clin Radiol"},{"key":"bib29-20230927","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/RLI.0000000000000176","article-title":"Correlation of quantitative dual-energy computed tomography iodine maps and abdominal computed tomography perfusion measurements: are single-acquisition dual-energy computed tomography iodine maps more than a reduced-dose surrogate of conventional computed tomography perfusion?","volume":"50","year":"2015","journal-title":"Invest Radiol"},{"key":"bib30-20230927","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cllc.2011.05.004","article-title":"Role of positron emission tomography in the early prediction of response to chemotherapy in patients with non\u2013small-cell lung cancer","volume":"13","year":"2012","journal-title":"Clin Lung Cancer"},{"key":"bib31-20230927","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/1754-9485.12427","article-title":"Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2\u2032-deoxy-2\u2032-[18F] fluoro-D-glucose-PET\/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC)","volume":"60","year":"2016","journal-title":"J Med Imaging Radiat Oncol"},{"key":"bib32-20230927","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1748-717X-7-152","article-title":"Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer","volume":"7","year":"2012","journal-title":"Radiat Oncol"},{"key":"bib33-20230927","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MNM.0b013e328351d4f5","article-title":"Prognostic value of volumetric parameters measured by F-18 FDG PET\/CT in surgically resected non-small-cell lung cancer","volume":"33","year":"2012","journal-title":"Nucl Med Commun"},{"key":"bib34-20230927","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00330-011-2251-y","article-title":"Comparison of image quality and radiation dose of different pulmonary CTA protocols on a 128-slice CT: high-pitch dual source CT, dual energy CT and conventional spiral CT","volume":"22","year":"2012","journal-title":"Eur Radiol"},{"key":"bib35-20230927","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/j.sult.2010.06.001","article-title":"Dual-energy derived virtual nonenhanced computed tomography imaging: current status and applications","volume":"31","year":"2010","journal-title":"Semin Ultrasound CT MR"}],"container-title":["Journal of Computer Assisted Tomography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004728-201807000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T18:08:15Z","timestamp":1695838095000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004728-201807000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rct.0000000000000734","relation":{},"ISSN":["1532-3145","0363-8715"],"issn-type":[{"value":"1532-3145","type":"electronic"},{"value":"0363-8715","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}